# Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion

> **NCT01451034** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 872 (actual)

## Conditions studied

- WHYX Lesion
- Extremely Well Differentiated Intestinal-type Adenocarcinoma

## Interventions

- **PROCEDURE:** WHYX cancer group

## Key facts

- **NCT ID:** NCT01451034
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 872 (ACTUAL)
- **Last updated:** 2011-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01451034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01451034, "Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01451034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*